|
GB1293565A
(en)
|
1969-05-03 |
1972-10-18 |
Aspro Nicholas Ltd |
Aminophthalazines and pharmaceutical compositions thereof
|
|
GB1303061A
(https=)
*
|
1969-05-03 |
1973-01-17 |
|
|
|
GB2063249A
(en)
*
|
1979-10-09 |
1981-06-03 |
Mitsubishi Yuka Pharma |
4-Phenylphthalazine derivatives
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
WO1989011279A1
(en)
|
1988-05-16 |
1989-11-30 |
Georgia State University Foundation, Inc. |
Nucleic acid interacting unfused heteropolycyclic compounds
|
|
JPH03284669A
(ja)
*
|
1990-03-30 |
1991-12-16 |
Mitsubishi Kasei Corp |
４―フェニルフタラジン誘導体
|
|
ES2068413T3
(es)
|
1990-03-30 |
1995-04-16 |
Mitsubishi Chem Ind |
Derivados de 4-fenilftalazina.
|
|
TW279162B
(https=)
*
|
1991-09-26 |
1996-06-21 |
Mitsubishi Chem Corp |
|
|
JP2668163B2
(ja)
|
1992-01-23 |
1997-10-27 |
ファイザー インク． |
コレステロール血症および抗アテローム動脈硬化症薬としての４−アリール−３−（ヘテロアリールウレイド）−１，２−ジヒドロ−２−オキソ−キノリン誘導体
|
|
US5565472A
(en)
|
1992-12-21 |
1996-10-15 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
|
|
DE4417746A1
(de)
|
1994-05-20 |
1995-11-23 |
Bayer Ag |
Neue Farbstoffe zum Massefärben von Kunststoffen
|
|
WO1996005176A1
(en)
*
|
1994-08-09 |
1996-02-22 |
Eisai Co., Ltd. |
Fused pyridazine compound
|
|
US5763263A
(en)
|
1995-11-27 |
1998-06-09 |
Dehlinger; Peter J. |
Method and apparatus for producing position addressable combinatorial libraries
|
|
US6288064B1
(en)
|
1996-08-20 |
2001-09-11 |
Eisai Co., Ltd. |
Remedy for erection failure comprising fused pyridazine compound
|
|
US20030124053A1
(en)
|
1996-10-07 |
2003-07-03 |
Barrett John Andrew |
Radiopharmaceuticals for imaging infection and inflammation
|
|
DE69720515T2
(de)
|
1996-12-18 |
2004-02-19 |
Neurogen Corp., Branford |
Isoquinolinamin und phtalazinamin derivate, die reagieren mit crf rezeptoren
|
|
US6486158B1
(en)
|
1998-08-14 |
2002-11-26 |
Cell Pathways, Inc. |
[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia
|
|
CA2368023A1
(en)
|
1999-03-22 |
2000-09-28 |
Guixue Yu |
Fused pyridopyridazine inhibitors of cgmp phosphodiesterase
|
|
ES2310626T3
(es)
|
2001-11-30 |
2009-01-16 |
Pfizer Products Inc. |
Compuestos azapoliciclicos condensados con arilo.
|
|
WO2004099158A1
(en)
|
2003-04-30 |
2004-11-18 |
Ricerca Biosciences, Llc. |
Monocyclic diazodioxide based bcl-2 protein antagonists
|
|
WO2005016000A1
(en)
|
2003-08-05 |
2005-02-24 |
Avalon Pharmaceuticals |
Derivatives of cyclic quinone and uses thereof
|
|
US7087621B2
(en)
|
2003-09-05 |
2006-08-08 |
Bristol-Myers Squibb Company |
Benzo- and azabenzodithiazole compounds
|
|
US8067608B2
(en)
|
2003-09-29 |
2011-11-29 |
The Johns Hopkins University |
Hedgehog pathway antagonists
|
|
EP1745039A4
(en)
|
2004-05-08 |
2009-07-22 |
Neurogen Corp |
3-ARYL-5,6-DISUBSTITUTED PYRIDAZINES
|
|
CA2569849C
(en)
|
2004-06-09 |
2012-11-27 |
Erick M. Carreira |
Monophosphine compounds, transition metal complexes thereof and production of optically active compounds using the complexes as asymmetric catalysts
|
|
US20060156485A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
WO2006090273A2
(en)
|
2005-02-22 |
2006-08-31 |
Warner-Lambert Company Llc |
[1,8]naphthyridin-2-ones and related compounds with keto or hydroxyl linkers for the treatment of schizophrenia
|
|
WO2006110516A1
(en)
|
2005-04-11 |
2006-10-19 |
Abbott Laboratories |
Acylhydrazide p2x7 antagonists and uses thereof
|
|
AU2006295397A1
(en)
|
2005-09-23 |
2007-04-05 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
|
FR2891828B1
(fr)
|
2005-10-12 |
2007-12-21 |
Sanofi Aventis Sa |
Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique
|
|
US7666898B2
(en)
|
2005-11-03 |
2010-02-23 |
Ilypsa, Inc. |
Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors
|
|
AU2006311851A1
(en)
|
2005-11-03 |
2007-05-18 |
Ilypsa, Inc. |
Azaindole compounds and use thereof as phospholipase-A2 inhibitors
|
|
WO2007056580A2
(en)
|
2005-11-08 |
2007-05-18 |
Pharmadyn, Inc. |
Methods and compositions for treating diseases associated with pathogenic proteins
|
|
JP2009120486A
(ja)
*
|
2005-12-05 |
2009-06-04 |
Mitsubishi Pharma Corp |
核内オーファン受容体の新規活性化剤及びその用途
|
|
US7560551B2
(en)
|
2006-01-23 |
2009-07-14 |
Amgen Inc. |
Aurora kinase modulators and method of use
|
|
AU2007208351C1
(en)
|
2006-01-23 |
2011-07-07 |
Amgen Inc. |
Aurora kinase modulators and method of use
|
|
CA2640307A1
(en)
|
2006-02-16 |
2007-08-23 |
Syngenta Participations Ag |
Pesticides containing a bicyclic bisamide structure
|
|
AU2007283401A1
(en)
|
2006-08-09 |
2008-02-14 |
Merck Frosst Canada Ltd. |
Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
|
|
MX2009011208A
(es)
|
2007-04-19 |
2009-10-30 |
Novartis Ag |
Derivados de acido nicotinico como moduladores del receptor de glutamato metabotropico-5.
|
|
US8097620B2
(en)
|
2007-05-04 |
2012-01-17 |
Amgen Inc. |
Diazaquinolones that inhibit prolyl hydroxylase activity
|
|
US9023490B2
(en)
|
2007-06-15 |
2015-05-05 |
Versitech Limited |
Extended pi-conjugated platinum (II) complexes
|
|
WO2009035568A1
(en)
|
2007-09-07 |
2009-03-19 |
Amgen Inc. |
Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
|
|
WO2009038812A1
(en)
|
2007-09-20 |
2009-03-26 |
Amgen Inc. |
Condensed piperidine derivatives useful as vanilloid receptor ligands
|
|
WO2009079008A1
(en)
|
2007-12-19 |
2009-06-25 |
Yangbo Feng |
Benzopyrans and analogs as rho kinase inhibitors
|
|
CA2709784A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US8932557B2
(en)
|
2008-02-14 |
2015-01-13 |
Eli Lilly And Company |
Imaging agents for detecting neurological dysfunction
|
|
EP2265604A4
(en)
|
2008-04-11 |
2011-10-26 |
Univ Michigan |
HETEROARYL-SUBSTITUTED BICYCLIC SMAC MIMETICA AND ITS APPLICATIONS
|
|
AU2009246626A1
(en)
|
2008-05-15 |
2009-11-19 |
Merck Sharp & Dohme Corp. |
Oxazolobenzimidazole derivatives
|
|
PL2285786T3
(pl)
|
2008-06-16 |
2014-01-31 |
Merck Patent Gmbh |
Pochodne chinoksalinodionowe
|
|
JP2010030992A
(ja)
|
2008-06-25 |
2010-02-12 |
M Carreira Erick |
光学活性アミン化合物の製造方法
|
|
JP2012500272A
(ja)
|
2008-08-16 |
2012-01-05 |
ジェネンテック， インコーポレイテッド |
Ｉａｐのアザインドールインヒビター
|
|
EP2346334A1
(en)
|
2008-09-26 |
2011-07-27 |
Merck Sharp & Dohme Corp. |
Oxazolobenzimidazole derivatives
|
|
BRPI1011477A2
(pt)
|
2009-03-02 |
2016-03-22 |
Sirtris Pharmaceuticals Inc |
quinolinas 8-substituidas e analogos relacionados como moduladores de sirtuina
|
|
TW201040191A
(en)
|
2009-03-27 |
2010-11-16 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
|
EP2414353A1
(en)
|
2009-04-01 |
2012-02-08 |
Basf Se |
Isoxazoline compounds for combating invertebrate pests
|
|
EP2417133A1
(en)
|
2009-04-06 |
2012-02-15 |
PTC Therapeutics, Inc. |
Compounds and methods for antiviral treatment
|
|
WO2010117936A1
(en)
|
2009-04-06 |
2010-10-14 |
Schering Corporation |
Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent
|
|
CN102625799A
(zh)
|
2009-06-25 |
2012-08-01 |
安姆根有限公司 |
杂环化合物及其用途
|
|
WO2011012883A1
(en)
|
2009-07-29 |
2011-02-03 |
Karus Therapeutics Limited |
Benzo [e] [1, 3 ] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
|
|
EP2464647B1
(en)
|
2009-08-11 |
2016-09-21 |
Bristol-Myers Squibb Company |
Azaindazoles as btk kinase modulators and use thereof
|
|
CN104530079B
(zh)
|
2009-12-18 |
2017-10-20 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
|
US8759535B2
(en)
|
2010-02-18 |
2014-06-24 |
High Point Pharmaceuticals, Llc |
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
|
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
|
WO2011146358A1
(en)
|
2010-05-21 |
2011-11-24 |
Merck Sharp & Dohme Corp. |
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
|
JP5826261B2
(ja)
|
2010-06-28 |
2015-12-02 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
癌に対する使用のためのキナーゼ阻害剤としての２，４−ジアリール置換［１，８］ナフチリジン
|
|
US20130079342A1
(en)
|
2010-06-30 |
2013-03-28 |
Paul John Dransfield |
Heterocyclic compounds and their uses
|
|
WO2012037132A1
(en)
|
2010-09-14 |
2012-03-22 |
Exelixis, Inc. |
Phtalazine derivatives as jak1 inhibitors
|
|
CA2810954A1
(en)
|
2010-09-27 |
2012-04-05 |
Abbott Gmbh & Co. Kg |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
|
US20140107151A1
(en)
|
2011-05-17 |
2014-04-17 |
Principia Biophama Inc. |
Tyrosine kinase inhibitors
|
|
WO2012156400A1
(en)
|
2011-05-18 |
2012-11-22 |
Syngenta Participations Ag |
Insecticidal compounds based on arylthioacetamide derivatives
|
|
CN103702984B
(zh)
|
2011-08-08 |
2016-05-11 |
默克专利股份公司 |
作为溶血磷脂酸拮抗剂的n-(苯并咪唑-2-基)-环丙烷甲酰胺类
|
|
WO2013026939A1
(en)
|
2011-08-25 |
2013-02-28 |
Syngenta Participations Ag |
Methods for the control of termites and ants
|
|
WO2013078254A1
(en)
|
2011-11-22 |
2013-05-30 |
Array Biopharma Inc. |
Bicyclic heteroaryl derivatives as kinase inhibitors
|
|
UA112897C2
(uk)
|
2012-05-09 |
2016-11-10 |
Байєр Фарма Акцієнгезелльшафт |
Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань
|
|
CN107011342A
(zh)
|
2012-05-22 |
2017-08-04 |
伊莱利利公司 |
用于检测神经功能障碍的基于咔啉和咔唑的成像剂
|
|
TWI610916B
(zh)
|
2012-08-03 |
2018-01-11 |
廣東東陽光藥業有限公司 |
作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用
|
|
WO2014079941A1
(en)
|
2012-11-21 |
2014-05-30 |
Syngenta Participations Ag |
Insecticidal compounds based on n-(arylsulfanylmethyl) carboxamide derivatives
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
WO2014079935A1
(en)
|
2012-11-21 |
2014-05-30 |
Syngenta Participations Ag |
Insecticidal compounds based on arylthioacetamide derivatives
|
|
WO2014086737A1
(de)
|
2012-12-06 |
2014-06-12 |
Bayer Cropscience Ag |
Kondensierte 2-pyridon-3-carboxamide und ihre verwendung als herbizide
|
|
TW201439060A
(zh)
|
2013-02-27 |
2014-10-16 |
Sunshine Lake Pharma Co Ltd |
作爲丙型肝炎抑制劑的橋環化合物及其藥物組合物和用途
|
|
GB201311953D0
(en)
*
|
2013-07-03 |
2013-08-14 |
Redx Pharma Ltd |
Compounds
|
|
AR097631A1
(es)
|
2013-09-16 |
2016-04-06 |
Bayer Pharma AG |
Trifluorometilpirimidinonas sustituidas con heterociclos y sus usos
|
|
UY35809A
(es)
|
2013-11-05 |
2015-05-29 |
Bayer Pharma AG |
(aza)piridopirazolopirimidinonas e indazolopirimidinonas y sus usos
|
|
MA39838B1
(fr)
|
2014-04-04 |
2019-05-31 |
Pfizer |
Composés bicycliques hétéroaryle ou aryle fusionnés et leur utilisation en tant qu'inhibiteurs irak4
|
|
CN103992311B
(zh)
*
|
2014-06-20 |
2017-01-25 |
东南大学 |
Hedgehog信号通路抑制剂
|
|
US9617279B1
(en)
|
2014-06-24 |
2017-04-11 |
Bristol-Myers Squibb Company |
Imidazooxadiazole compounds
|
|
US9763922B2
(en)
|
2014-11-27 |
2017-09-19 |
Genentech, Inc. |
Therapeutic compounds and uses thereof
|
|
CN107438612A
(zh)
|
2014-12-22 |
2017-12-05 |
阿卡纳治疗学有限公司 |
用于治疗疾病的稠合双环化合物
|
|
WO2016123796A1
(en)
|
2015-02-06 |
2016-08-11 |
Abbvie Inc. |
Substituted phthalazines
|
|
SI3259253T1
(sl)
|
2015-02-16 |
2020-07-31 |
The University Of Queensland |
Sulfonilsečnine in sorodne spojine ter njihova uporaba
|
|
EA201800367A1
(ru)
|
2015-12-10 |
2019-02-28 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
Способы лечения болезни хантингтона
|
|
FR3046933B1
(fr)
|
2016-01-25 |
2018-03-02 |
Galderma Research & Development |
Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires
|
|
JP6849197B2
(ja)
|
2016-02-12 |
2021-03-24 |
ファーマクシス リミテッド |
リジルオキシダーゼのインドールおよびアザインドールハロアリルアミン誘導体阻害剤およびその使用
|
|
JP2019512009A
(ja)
|
2016-02-16 |
2019-05-09 |
ザ・ユニバーシティ・オブ・クイーンズランド |
スルホニルウレアおよび関連化合物ならびにこれらの利用
|
|
WO2017144341A1
(de)
|
2016-02-23 |
2017-08-31 |
Bayer Cropscience Aktiengesellschaft |
Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
|
|
US11339136B2
(en)
|
2016-04-18 |
2022-05-24 |
Novartis Ag |
Compounds and compositions for treating conditions associated with NLRP activity
|
|
US11447460B2
(en)
|
2016-04-18 |
2022-09-20 |
Novartis Ag |
Compounds and compositions for treating conditions associated with NLRP activity
|
|
EP3236267B1
(en)
|
2016-04-18 |
2021-09-08 |
Roche Diagnostics GmbH |
Decapper and apparatus
|
|
EP3272739A1
(en)
|
2016-07-20 |
2018-01-24 |
NodThera Limited |
Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
|
|
WO2018031680A1
(en)
|
2016-08-10 |
2018-02-15 |
Fronthera U.S. Pharmaceuticals Llc |
Novel compounds, uses and methods for their preparation
|
|
WO2018080216A1
(en)
*
|
2016-10-28 |
2018-05-03 |
Daewoong Pharmaceutical Co., Ltd. |
Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same
|
|
WO2018138050A1
(de)
|
2017-01-26 |
2018-08-02 |
Bayer Aktiengesellschaft |
Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
|
|
BR112019015484A2
(pt)
|
2017-01-31 |
2020-04-28 |
Arvinas Operations Inc |
ligantes de cereblon e compostos bifuncionais compreendendo os mesmos
|
|
WO2018172925A1
(en)
|
2017-03-23 |
2018-09-27 |
Vitas Pharma Research Pvt Ltd |
Inhibitors of dna gyrase for treatment of bacterial infections
|
|
WO2018174678A1
(ko)
|
2017-03-24 |
2018-09-27 |
희성소재(주) |
헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
|
|
KR20180108426A
(ko)
|
2017-03-24 |
2018-10-04 |
희성소재 (주) |
헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
|
|
EA201992781A1
(ru)
|
2017-05-22 |
2020-04-01 |
Эмджен Инк. |
Ингибиторы g12c kras и способы их применения
|
|
JP2020521741A
(ja)
|
2017-05-25 |
2020-07-27 |
アラクセス ファーマ エルエルシー |
がんの処置のための化合物およびその使用の方法
|
|
WO2018221433A1
(ja)
|
2017-05-29 |
2018-12-06 |
第一三共株式会社 |
ヘテロアリールアミン誘導体
|
|
KR102101559B1
(ko)
|
2017-07-20 |
2020-04-17 |
주식회사 엘지화학 |
화합물 및 이를 포함하는 유기 발광 소자
|
|
MA49903A
(fr)
|
2017-08-15 |
2020-06-24 |
Inflazome Ltd |
Sulfonylureés et sulfonylthioureés en tant qu'inhibiteurs de nlrp3
|
|
AU2018320673B2
(en)
|
2017-08-21 |
2023-03-30 |
Merck Patent Gmbh |
Benzimidazole derivatives as adenosine receptor antagonists
|
|
CN110526898A
(zh)
|
2018-05-25 |
2019-12-03 |
北京诺诚健华医药科技有限公司 |
3-吲唑啉酮类化合物、其制备方法及其在医药学上的应用
|
|
CN110563722A
(zh)
*
|
2018-06-06 |
2019-12-13 |
上海青煜医药科技有限公司 |
吡啶或哒嗪并环化合物及其应用
|
|
WO2020021015A1
(en)
|
2018-07-26 |
2020-01-30 |
Esteve Pharmaceuticals, S.A. |
New imidazopyridine derivatives for treating pain and pain related conditions
|
|
US12453279B2
(en)
|
2018-08-22 |
2025-10-21 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
KR102925387B1
(ko)
|
2019-02-04 |
2026-02-10 |
스카이호크 테라퓨틱스, 인코포레이티드 |
스플라이싱을 조절하는 방법 및 조성물
|
|
KR102721075B1
(ko)
|
2019-02-15 |
2024-10-24 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
|
UY38687A
(es)
*
|
2019-05-17 |
2023-05-15 |
Novartis Ag |
Inhibidores del inflamasoma nlrp3, composiciones, combinaciones de los mismos y métodos para su uso
|
|
US11618751B1
(en)
|
2022-03-25 |
2023-04-04 |
Ventus Therapeutics U.S., Inc. |
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
|
|
AR121669A1
(es)
*
|
2020-03-27 |
2022-06-29 |
Astellas Pharma Inc |
Compuesto de piridazina sustituida
|
|
US20230202989A1
(en)
|
2020-05-28 |
2023-06-29 |
Janssen Pharmaceutica Nv |
Compounds
|
|
GB2595975B
(en)
|
2020-06-09 |
2022-12-07 |
Pardes Biosciences Inc |
Inhibitors of cysteine proteases and methods of use thereof
|
|
CN116390914A
(zh)
|
2020-12-25 |
2023-07-04 |
上海拓界生物医药科技有限公司 |
一类含哒嗪的化合物及其医药用途
|
|
WO2022166890A1
(zh)
|
2021-02-08 |
2022-08-11 |
南京明德新药研发有限公司 |
取代的哒嗪苯酚类衍生物
|
|
US11319319B1
(en)
|
2021-04-07 |
2022-05-03 |
Ventus Therapeutics U.S., Inc. |
Compounds for inhibiting NLRP3 and uses thereof
|
|
MX2023011709A
(es)
|
2021-04-07 |
2023-10-12 |
Forma Therapeutics Inc |
Inhibidor de la proteasa 1 especifica de ubiquitina (usp1).
|
|
US20240239758A1
(en)
|
2021-04-28 |
2024-07-18 |
Astellas Pharma Inc. |
Substituted triazine compound
|
|
AU2022263621A1
(en)
|
2021-04-29 |
2023-12-14 |
Janssen Pharmaceutica Nv |
Phthalazinone derivatives as nlrp3 inflammasome inhibitors
|
|
SI4337652T1
(sl)
|
2021-05-12 |
2025-07-31 |
F. Hoffmann-La Roche Ag |
Zaviralci NLRP3
|
|
KR20240019083A
(ko)
|
2021-06-04 |
2024-02-14 |
에프. 호프만-라 로슈 아게 |
트리아진 유도체 및 암 치료에서 이의 용도
|
|
WO2022253326A1
(zh)
|
2021-06-05 |
2022-12-08 |
药捷安康(南京)科技股份有限公司 |
Nlrp3炎症小体抑制剂及其应用
|
|
US20240327413A1
(en)
|
2021-06-29 |
2024-10-03 |
Zomagen Biosciences Ltd |
Nlrp3 modulators
|
|
HRP20251513T1
(hr)
|
2021-07-02 |
2026-01-02 |
Astrazeneca Ab |
Inhibitori inflamasoma nlrp3
|
|
JP2024525589A
(ja)
|
2021-07-09 |
2024-07-12 |
アリゴス セラピューティクス インコーポレイテッド |
抗ウイルス化合物
|
|
MX2024000984A
(es)
|
2021-07-21 |
2024-06-19 |
Nico Therapeutics Inc |
Compuesto de piridazina anilado.
|
|
IL310992A
(en)
|
2021-08-25 |
2024-04-01 |
Ptc Therapeutics Inc |
NLRP3 inhibitors
|
|
CN117858871A
(zh)
|
2021-08-25 |
2024-04-09 |
兹杜斯生命科学有限公司 |
用于神经炎性病症的治疗
|
|
WO2023028536A1
(en)
|
2021-08-25 |
2023-03-02 |
Ptc Therapeutics, Inc. |
1,2,4-triazine derivatives useful as inhibitors of nlrp3
|
|
US20240391881A1
(en)
|
2021-09-30 |
2024-11-28 |
Origiant Pharmaceutical Co., Ltd. |
Pharmaceutical use and preparation method for substituted heteroaryl phthalazine derivative
|
|
AR127386A1
(es)
|
2021-10-19 |
2024-01-17 |
Hoffmann La Roche |
Compuestos heteroarilicos bicíclicos fusionados útiles como inhibidores de nlrp3
|
|
CN116102535A
(zh)
|
2021-10-22 |
2023-05-12 |
索智生物科技（浙江）有限公司 |
一种含氮化合物、其制备方法及应用
|
|
WO2023088856A1
(en)
|
2021-11-17 |
2023-05-25 |
F. Hoffmann-La Roche Ag |
Heterocyclic nlrp3 inhibitors
|
|
JP2024540525A
(ja)
|
2021-11-19 |
2024-10-31 |
エフ． ホフマン－ラ ロシュ アーゲー |
Ｎｌｒｐ３の阻害剤としてのピリダジン誘導体
|
|
US20250074888A1
(en)
|
2021-12-29 |
2025-03-06 |
Neumora Therapeutics, Inc. |
Pyridazine derivatives as modulators of nlrp3 inflammasome and related methods
|
|
IL314025A
(en)
|
2022-01-07 |
2024-08-01 |
Transthera Sciences Nanjing Inc |
Nlrp3 inflammasome inhibitor and uses thereof
|
|
CN116726020A
(zh)
|
2022-03-08 |
2023-09-12 |
上海拓界生物医药科技有限公司 |
一类含哒嗪的化合物的药物组合物及其医药用途
|
|
EP4493556A4
(en)
|
2022-03-15 |
2026-03-18 |
Zomagen Biosciences Ltd |
NLRP3 MODULATORS
|
|
CN119137121A
(zh)
|
2022-03-25 |
2024-12-13 |
万特斯治疗美国公司 |
可用作NLRP3衍生物的吡啶并-[3,4-d]哒嗪胺衍生物
|
|
EP4499646A4
(en)
|
2022-03-31 |
2026-03-18 |
Hangzhou Highlightll Pharmaceutical Co Ltd |
NLRP3 Inflammasome Inhibitors
|
|
AR129012A1
(es)
|
2022-04-07 |
2024-07-03 |
Takeda Pharmaceuticals Co |
Derivados de piridazina fusionados
|
|
CN116969920A
(zh)
|
2022-04-29 |
2023-10-31 |
上海辉启生物医药科技有限公司 |
稠合哒嗪衍生物及其制备方法与医药用途
|
|
CA3251149A1
(en)
|
2022-05-13 |
2023-11-16 |
Neumora Therapeutics, Inc. |
NLRP3 INFLAMMASOME MODULATORS, ASSOCIATED PRODUCTS AND PROCESSES
|
|
JP2025519226A
(ja)
|
2022-06-03 |
2025-06-24 |
エフ． ホフマン－ラ ロシュ アーゲー |
新規化合物
|
|
WO2024006559A1
(en)
|
2022-07-01 |
2024-01-04 |
Neumora Therapeutics, Inc. |
Modulators of nlrp3 inflammasome and related products and methods
|
|
EP4554945A1
(en)
|
2022-07-14 |
2025-05-21 |
AC Immune SA |
Pyrrolotriazine and imidazotriazine derivatives as modulators of the nlrp3 inflammasome pathway
|
|
CN119546599A
(zh)
|
2022-07-14 |
2025-02-28 |
南京明德新药研发有限公司 |
氘取代的哒嗪苯并噻吩化合物及其应用
|
|
US20260015353A1
(en)
|
2022-07-21 |
2026-01-15 |
Hoffmann-La Roche Inc. |
Novel compounds
|
|
AU2023313032A1
(en)
|
2022-07-28 |
2025-01-23 |
Ac Immune Sa |
Novel compounds
|
|
UY40374A
(es)
|
2022-08-03 |
2024-02-15 |
Novartis Ag |
Inhibidores de inflamasoma nlrp3
|
|
AR130151A1
(es)
|
2022-08-10 |
2024-11-06 |
Takeda Pharmaceuticals Co |
Compuesto heterocíclico
|
|
CN116789674B
(zh)
|
2022-08-24 |
2024-05-24 |
杭州高光制药有限公司 |
Nlrp3炎性小体抑制剂
|
|
GEAP202516743A
(en)
|
2022-09-23 |
2025-08-11 |
Merck Sharp & Dohme Llc |
Phthalazine derivatives useful as inhibitors of nod-like receptor protein 3
|
|
EP4610258A1
(en)
|
2022-10-26 |
2025-09-03 |
Tenvie Therapeutics, Inc. |
Fused pyridazine derivative
|
|
WO2024097629A1
(en)
|
2022-10-31 |
2024-05-10 |
Ventus Therapeutics U.S., Inc. |
Bridged bicyclic heterocycloalkyl pyrido-[3,4-d]pyridazine amine derivatives useful as nlrp3 inhibitors
|
|
US12331048B2
(en)
|
2022-10-31 |
2025-06-17 |
Ventus Therapeutics U.S., Inc. |
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
|
|
EP4611743A1
(en)
|
2022-11-02 |
2025-09-10 |
Merck Sharp & Dohme LLC |
Triazines useful as inhibitors of nod-like receptor protein 3
|
|
WO2024094150A1
(en)
|
2022-11-04 |
2024-05-10 |
Insilico Medicine Ip Limited |
Nlrp3 inflammasome inhibitors and uses thereof
|
|
WO2024094185A1
(zh)
|
2022-11-04 |
2024-05-10 |
药捷安康(南京)科技股份有限公司 |
Nlrp3炎症小体抑制剂及其应用
|
|
EP4615841A1
(en)
|
2022-11-09 |
2025-09-17 |
F. Hoffmann-La Roche AG |
Triazinone derivatives as nlrp3 inhibitors
|
|
AR130983A1
(es)
|
2022-11-09 |
2025-02-05 |
Hoffmann La Roche |
Derivados de triazinona inhibidores de nlrp3
|
|
EP4615830A1
(en)
|
2022-11-09 |
2025-09-17 |
F. Hoffmann-La Roche AG |
Triazinone derivatives as nlrp3 inhibitors
|
|
CN118056822A
(zh)
|
2022-11-18 |
2024-05-21 |
正大天晴药业集团股份有限公司 |
一种哒嗪并环化合物及其用途
|
|
WO2024109922A1
(zh)
|
2022-11-25 |
2024-05-30 |
成都赜灵生物医药科技有限公司 |
桥环并哒嗪类化合物及其用途
|
|
WO2024121086A1
(en)
|
2022-12-07 |
2024-06-13 |
F. Hoffmann-La Roche Ag |
Novel compounds as modulators of nlrp3 inhibition
|
|
CN120303272A
(zh)
|
2022-12-08 |
2025-07-11 |
豪夫迈·罗氏有限公司 |
Nlrp3的抑制剂
|
|
WO2024137319A1
(en)
|
2022-12-19 |
2024-06-27 |
Merck Sharp & Dohme Llc |
6,6 bicyclic heterocyles useful as inhibitors of nod-like receptor protein 3
|
|
KR20250137593A
(ko)
|
2022-12-23 |
2025-09-18 |
뉴모라 테라퓨틱스, 인코포레이티드 |
Nlrp3 인플라마솜의 조정제 및 관련 생성물 및 방법
|
|
CN120379995A
(zh)
|
2022-12-27 |
2025-07-25 |
正大天晴药业集团股份有限公司 |
一种哒嗪稠芳环化合物及其用途
|
|
KR20250106322A
(ko)
|
2022-12-28 |
2025-07-09 |
장춘 진사이언스 파마슈티컬 씨오., 엘티디. |
피리다진계 nlrp3 억제제 화합물, 약학 조성물 및 이의 제조 방법과 용도
|
|
UY40587A
(es)
|
2022-12-28 |
2024-07-31 |
Astrazeneca Ab |
Inhibidores del inflamasoma nlrp3
|
|
WO2024145623A1
(en)
|
2022-12-30 |
2024-07-04 |
Ptc Therapeutics, Inc. |
Heterocyclic and heteroaryl compounds as inhibitors of nlrp3
|
|
EP4646197A2
(en)
|
2023-01-03 |
2025-11-12 |
Kodiak Sciences Inc. |
Organic compounds as nlrp3 inhibitors
|
|
CN120957980A
(zh)
|
2023-01-31 |
2025-11-14 |
詹森药业有限公司 |
作为nlrp3抑制剂的2-(哒嗪-3-基)-5-(三氟甲基)苯酚
|
|
CN120981462A
(zh)
|
2023-01-31 |
2025-11-18 |
詹森药业有限公司 |
咪唑并[1,2-d][1,2,4]三嗪作为NLRP3抑制剂
|
|
WO2024160694A1
(en)
|
2023-01-31 |
2024-08-08 |
Janssen Pharmaceutica Nv |
[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AND [1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS NLRP3 INHIBITORS
|
|
KR20250134147A
(ko)
|
2023-01-31 |
2025-09-09 |
얀센 파마슈티카 엔브이 |
NLRP3 억제제로서의 피롤로[1,2-d][1,2,4]트리아진 및 피라졸로[1,5-d] [1,2,4]트리아진
|
|
CN121001996A
(zh)
|
2023-01-31 |
2025-11-21 |
詹森药业有限公司 |
作为nlrp3抑制剂的吡啶-2(1h)-酮和嘧啶-4(3h)-酮
|